Navamedic investor relations material

Navamedic ASA is a Norwegian pharmaceutical company developing, producing, marketing and selling prescription and non-prescription pharmaceuticals, medical nutrition products and medical devices in the Nordic region. The company offers prescription products for use in the treatment of a variety of conditions including: phenylketonuria; homocystinuria; maple syrup urine disease; tyrosinemia, methylmalonic acidemia/propionic acidemia; glutaric aciduria, isovaleric acidemia and urea cycle disorders.